acmefirewoodis...(put something here)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Shorts are becoming more impotent as news gets out to the market about the huge potential that the company's patented MANF technology offers.
This is substantially undervalued. It should be trading in the .15-.20 range currently.
If you're wondering what stock may be the "2013 Stock of the Year" and what C.E.O. may be the "2013 Bio-Tech C.E.O. of the Year" I think you've already got a head start on knowing the winners.
Exciting months ahead for the shareholders.
"Big pharma" development partnership or buyout in 2013.
Target Price: $1.00
Anyone selling/shorting here should get out of the market.
A very Merry Christmas for the shareholders.
"Big pharma" development partnership or buyout in 2013.
Major drug companies are flush with cash and are faced with many of their major drugs going over the "patent cliff".
Company's patented MANF technology could be worth billions in future revenues.
Interesting months ahead for the shareholders.
Target price: $1.00
I expect a development partnership with a "big pharma" drug company or a buyout some time in 2013.
Although on the high side $1.00 is not out of the question.
Anyone selling or not buying here will regret it very soon as the move higher starts gaining traction.
Best opportunity in the market to make a substantial profit in 2013 is right in front of you.
I can't find another stock that has the potential upside that AMBS offers to anyone buying at the current depressed price.
It should be trading in the .15 range currently.
The word is getting out to the market.
Tremendous upside ahead.
Was I specific as to which Christmas I was referring? :)
Good example of what can happen when someone assumes that the information that someone is receiving is in fact what is really the situation. Management didn't meet the highest standard of honesty or disclosure.
Who's selling .50 shares for under four cents?
Big pharma development partnership or buyout takes this to .50.
"Patience is a virtue."
The MANF comparative study will be the catalyst to start this moving seriously higher.
A very "Merry Christmas" in store for the shareholders.
Strong accumulation and the base continues to move higher.
Should be in the .05-.06 range by Friday.
Another day closer to great news.
Why don't you call Universal Drilling in Wickenberg,AZ. As I recall the owner's name is Doug. He will answer your questions.
390 West Bonita Drive Wickenburg, AZ 85390
(928) 684-2886
How long are you guys going to beat a dead horse?
Anyone selling under two cents will regret it when the first gold revenues are reported. "Yes, they are recovering gold." :)
I'm expecting a move back to the .035 range.
Anyone who wants to sell shares for .015 or less is welcome to do so.
Thanks in advance.
p.s. I think there's a buy order on level 2 for 2,000,000 shares at .015 AON.
Shorts need to pick their poison: "Big pharma" development partnership or a buyout.
Either one takes this above .50 share.
Interesting times ahead for the shareholders.
Don't miss the run-up. :)
p.s. This is substantially undervalued at the current share price just based on what we know. The share price should be in the .12-.15 range currently.
This is overdue for a gap higher.
Shorts need millions of shares to cover with no where to find them with positive news on the way.
Hold on to your cheap shares.
They'll be worth many times the current price in two to three months.
.15-.20 by 12/31/2012.
When the company announces that they've been approached by a "big pharma" drug company regarding a potential buyout what do you think will happen to the share price?
Strong possibility it happens sooner than expected.
Buyout in the .50 or higher range is a strong possibility.
Amgen?
"Patience is a virtue."
Amarantus Bioscience is setting up to be the "perfect storm" for anyone buying at the current price to make substantial profits.
There's any number of realistic scenarios that will move the share price continually higher.
The market is just finding out about the upside that the company offers.
These opportunities are rare in the market.
Don't miss this one.
How many times have you read or heard about a stock that jumped 1,500% within a month or two and thought to yourself that you wished you'd heard about the stock and had the opportunity to buy shares at the bottom?
Amarantus Bioscience is setting up to be one of those stocks.
Obviously if you're reading this you now know of the tremendous upside that the current share price offers to anyone buying today.
2013 will be a very prosperous year for the company's shareholders.
MANF comparative study results expected within ten days.
Positive data and the resulting short squeeze will move this above .20.
Any additional press releases will take it higher.
The company is on the radar of a number of big pharma drug companies that are flush with cash and faced with many of their major drugs going over the "patent cliff".
Add a few shares at the bottom before it gaps higher.
The company could be a strong candidate for the 2013 Stock of the Year.
Impressive accumulation. Someone wants in badly.
Shorts may want to cover here.
.15-.20 with positive study results. Up from there.
This is substantially undervalued.
Should be at .15 here.
Strong accumulation underway.
Positive comparative study results leaking?
Overdue for a gap-up. .05-.06 tomorrow?
Word is getting out to the market about the legitimate upside that this company offers.
Short squeeze is just starting.
Amazing that anyone is selling/shorting here with the comparative study results due out at any time.
Hold on to your cheap shares. This is due for a substantial move higher.
Bogart must have known about AMBS when he commented in Casablanca about anyone who is selling here regretting it "maybe not today or tomorrow but soon and for the rest of their life."
A very Merry Christmas awaits the shareholders followed by a very prosperous 2013 and beyond.
I think you're pretty much on target with your comments.
The company's C.E.O. should have issued an update once they realized that they wouldn't be using the Alaskan-25 unit and that the start of actual gold production would be delayed.
I don't doubt that they are putting a 100% effort in the attempt to make the company a financial success.
I was expecting a sprint and got a marathon.
Appears that shares below .03 will soon be non-existent.
Strong accumulation by new shareholders that will hold for the long term appears to be happening.
This is at or near the forward moving bottom here.
2013 will be a very good year for the shareholders.
p.s. A co-founder of Amgen doesn't invest money in a company and become a director without a strong belief that the company has something promising to offer.
.15 by 12/31/2012.
Comparative study data gaps this substantially higher.
Shorts are going to get squeezed badly.
A very Merry Christmas for the shareholders.
If you don't own shares and think it's a bad investment why are you wasting your time posting on the board?
Why not use your time to raise money for a charity such as the Salvation Army. I'm certain they could use another bell ringer this time of the year. Bake some Christmas cookies and take them to a local assisted living facility.
Don't waste your time posting on a stock board for a penny stock in which you have no interest in investing.
It doesn't cost anything to disagree.
It's unfortunate that there will probably be no revenue reporting by the company until the first or second week or January.
Penny stocks typically don't do well when news is lacking.
Obviously my previous price targets are, in the short term, out the window.
The question now is how low will the share price go over the next four weeks and at what price should shares be purchased.
Interesting weeks ahead.
Don't miss the opportunity to buy shares at the bottom. The right news could send this substantially higher at any time.
On the sidelines waiting for a better price is not the place to be with this stock.
Good luck to all the "AMBS" shareholders both old and new.
p.s. The company's management is doing a lot of things right to increase shareholder value.
I agree 100% if what you are saying is correct. Considering the availability of information on the internet and the willingness of the company to have shareholders visit the site it would make no sense for the company to distort the facts about which production equipment it is using at the Tarantula site.
It is too easy to verify or note any discrepancies.
There should be no need for the management to not convey factual information to the shareholders.
Wait a day or two and I think you might be able to get in under .04 or possibly higher if we get another positive press release.
Can anyone that has visited the Tarantula site confirm that the company has a backup production unit?
Since the company didn't purchase the Alaskan-25 unit as announced it's quite possible that they did invest in a back-up unit.
Did anyone see one of these?
http://www.goldhog.com/gold_hog_highbanker.htm
p.s. I expect the first gold revenue report will either take the share price below .01 or above .04.
I'm expecting above .04. :)
Of all the 1,000's of penny stocks that are currently being traded I can't find another one that has more potential upside than this one.
I don't see how anyone can pass on the opportunity to buy a few shares at the current price.
The comparative study results should draw additional substantial attention to the company from the market and new investors.
I'm expecting a very Merry Christmas and a very prosperous 2013 for all the company's shareholders.
Would half a gram per ton be considered good or bad?
.20-.25 or higher with positive news is possible.
My target range was prior to the news being released.
Current share price is a gift for both the short and long term.
IMHO.
Any post referencing a reverse split is probably either a short or someone who wants a better price. It is often said that a drowning man will grasp at straws.
Don't put yourself in that situation.
Buy a few shares at the open tomorrow and you'll have a very prosperous 2013.
Will Gerald E. Commissiong be the 2013 Bio-Tech C.E.O. of the Year?
Interesting year ahead for the company and its shareholders.
Don't pass up the opportunity to buy a few shares at the bottom before the comparative study results are released.
Great post. I especially think this comment is definitely on target:
"You don't get people like Dr. Joseph Rubinfeld, co-founder of Amgen, Dr. Robert Zimmerman from Bayer, and Clinton O. Allen from Bristol Myers Squibb hanging around with Gerald because he looks like Obama, he has something they want and its just a matter of time before one of them makes a move to get it."
.06-.08 by 12/21 in anticipation of the comparative study result.
>.15 if the results are positive.
p.s. The market is just discovering the potential upside that MANF offers.
.06-.08 by 12/21/2012 in anticipation of the study results.
Interesting times ahead for the shareholders.
Accumulation continues as the market is finding out about the potential that the company offers.
GLTA
p.s. A very Merry Christmas for the company and its shareholders and a very prosperous 2013.
Clear,concise, and to the point.
Like to get another 2,000,000 shares before the real run-up begins.
Was hoping for a pull back to .025 today. :(